vs
Side-by-side financial comparison of BRANDYWINE REALTY TRUST (BDN) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $127.0M, roughly 1.5× BRANDYWINE REALTY TRUST). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -38.4%, a 39.3% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 4.5%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 0.7%).
Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
BDN vs FOLD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $127.0M | $185.2M |
| Net Profit | $-48.8M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | 1.2% | 8.6% |
| Net Margin | -38.4% | 0.9% |
| Revenue YoY | 4.5% | 23.7% |
| Net Profit YoY | -80.4% | -88.5% |
| EPS (diluted) | $-0.28 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $127.0M | — | ||
| Q4 25 | $121.0M | $185.2M | ||
| Q3 25 | $121.4M | $169.1M | ||
| Q2 25 | $120.6M | $154.7M | ||
| Q1 25 | $121.5M | $125.2M | ||
| Q4 24 | $121.9M | $149.7M | ||
| Q3 24 | $131.8M | $141.5M | ||
| Q2 24 | $125.3M | $126.7M |
| Q1 26 | $-48.8M | — | ||
| Q4 25 | $-36.7M | $1.7M | ||
| Q3 25 | $-25.9M | $17.3M | ||
| Q2 25 | $-88.7M | $-24.4M | ||
| Q1 25 | $-27.0M | $-21.7M | ||
| Q4 24 | $-44.5M | $14.7M | ||
| Q3 24 | $-165.2M | $-6.7M | ||
| Q2 24 | $30.2M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | 61.3% | 85.7% | ||
| Q3 25 | 62.6% | 88.5% | ||
| Q2 25 | 62.4% | 90.2% | ||
| Q1 25 | 60.8% | 90.7% | ||
| Q4 24 | 61.2% | 90.1% | ||
| Q3 24 | 64.9% | 90.6% | ||
| Q2 24 | 63.1% | 91.1% |
| Q1 26 | 1.2% | — | ||
| Q4 25 | 22.8% | 8.6% | ||
| Q3 25 | 20.8% | 20.3% | ||
| Q2 25 | -34.3% | -6.1% | ||
| Q1 25 | 12.5% | -6.3% | ||
| Q4 24 | 18.0% | 10.7% | ||
| Q3 24 | -7.2% | 15.3% | ||
| Q2 24 | 15.5% | 11.8% |
| Q1 26 | -38.4% | — | ||
| Q4 25 | -30.3% | 0.9% | ||
| Q3 25 | -21.3% | 10.2% | ||
| Q2 25 | -73.5% | -15.8% | ||
| Q1 25 | -22.2% | -17.3% | ||
| Q4 24 | -36.5% | 9.8% | ||
| Q3 24 | -125.4% | -4.8% | ||
| Q2 24 | 24.1% | -12.4% |
| Q1 26 | $-0.28 | — | ||
| Q4 25 | $-0.21 | $0.00 | ||
| Q3 25 | $-0.15 | $0.06 | ||
| Q2 25 | $-0.51 | $-0.08 | ||
| Q1 25 | $-0.16 | $-0.07 | ||
| Q4 24 | $-0.25 | $0.05 | ||
| Q3 24 | $-0.96 | $-0.02 | ||
| Q2 24 | $0.17 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.2M | $293.5M |
| Total DebtLower is stronger | — | $392.7M |
| Stockholders' EquityBook value | — | $274.2M |
| Total Assets | $3.6B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $36.2M | — | ||
| Q4 25 | $32.3M | $293.5M | ||
| Q3 25 | $75.5M | $263.8M | ||
| Q2 25 | $122.6M | $231.0M | ||
| Q1 25 | $29.4M | $250.6M | ||
| Q4 24 | $90.2M | $249.9M | ||
| Q3 24 | $36.5M | $249.8M | ||
| Q2 24 | $30.4M | $260.1M |
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $392.7M | ||
| Q3 25 | $2.3B | $392.0M | ||
| Q2 25 | $2.3B | $391.3M | ||
| Q1 25 | $2.2B | $390.7M | ||
| Q4 24 | $2.2B | $390.1M | ||
| Q3 24 | $2.3B | $389.5M | ||
| Q2 24 | $2.2B | $388.9M |
| Q1 26 | — | — | ||
| Q4 25 | $792.7M | $274.2M | ||
| Q3 25 | $841.5M | $230.4M | ||
| Q2 25 | $879.8M | $204.3M | ||
| Q1 25 | $993.6M | $193.6M | ||
| Q4 24 | $1.0B | $194.0M | ||
| Q3 24 | $1.1B | $178.8M | ||
| Q2 24 | $1.3B | $132.5M |
| Q1 26 | $3.6B | — | ||
| Q4 25 | $3.6B | $949.9M | ||
| Q3 25 | $3.3B | $868.8M | ||
| Q2 25 | $3.4B | $815.3M | ||
| Q1 25 | $3.4B | $789.8M | ||
| Q4 24 | $3.5B | $785.0M | ||
| Q3 24 | $3.6B | $786.6M | ||
| Q2 24 | $3.8B | $749.5M |
| Q1 26 | — | — | ||
| Q4 25 | 3.23× | 1.43× | ||
| Q3 25 | 2.70× | 1.70× | ||
| Q2 25 | 2.63× | 1.92× | ||
| Q1 25 | 2.23× | 2.02× | ||
| Q4 24 | 2.13× | 2.01× | ||
| Q3 24 | 2.06× | 2.18× | ||
| Q2 24 | 1.73× | 2.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $16.3M |
| Free Cash FlowOCF − Capex | — | $16.0M |
| FCF MarginFCF / Revenue | — | 8.6% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | — | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $116.7M | $16.3M | ||
| Q3 25 | $47.5M | $35.7M | ||
| Q2 25 | $34.4M | $-26.5M | ||
| Q1 25 | $6.3M | $7.8M | ||
| Q4 24 | $181.1M | $-3.9M | ||
| Q3 24 | $52.2M | $-23.0M | ||
| Q2 24 | $48.2M | $22.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $16.0M | ||
| Q3 25 | — | $35.3M | ||
| Q2 25 | — | $-28.9M | ||
| Q1 25 | — | $7.5M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-23.3M | ||
| Q2 24 | — | $21.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.6% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | -2.8% | ||
| Q3 24 | — | -16.5% | ||
| Q2 24 | — | 17.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.2% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.62× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BDN
| Rents | $120.7M | 95% |
| Third party management fees, labor reimbursement and leasing | $4.7M | 4% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
